(Q69649833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

title

Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

1 reference

E A Llados i Vallory

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

R Girot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

G Lenoir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

M Payet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

P Houze

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

R Bourdon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

publication date

1 April 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pediatrics

4 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

volume

148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

page(s)

503-506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2744011%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00441542

4 October 2019

exact match

0 references

cites work

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron-Loaded Subjects

1 reference

12 December 2020

Prevention of iron loading in transfusion-dependent thalassaemia

1 reference

12 December 2020

Haemoglobin levels and blood requirement in thalassaemia

1 reference

12 December 2020

Desferrioxamine, ocular toxicity, and trace metals

1 reference

12 December 2020

Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients

1 reference

12 December 2020

Clinical management of thalassemia. Decreasing iron stores during intensive chelation therapy

1 reference

12 December 2020

[Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion]

1 reference

12 December 2020

Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload

1 reference

12 December 2020

Ferrioxamine excretion in iron-loaded man

1 reference

12 December 2020

Visual loss in patient on high-dose subcutaneous desferrioxamine

1 reference

12 December 2020

Auditory Involvement in Thalassemia Major

1 reference

12 December 2020

Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamine

1 reference

12 December 2020

Survival and desferrioxamine in thalassaemia major.

1 reference

12 December 2020

A study of the mechanisms and sites of action of desferrioxamine in thalassaemia major

1 reference

12 December 2020

Ocular toxicity of desferrioxamine

1 reference

12 December 2020

[Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)]

1 reference

12 December 2020

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions

1 reference

12 December 2020

Quantification of desferrioxamine in blood plasma by inductively coupled plasma atomic emission spectrometry

1 reference

12 December 2020

Continuous subcutaenous administration of deferoxamine in patients with iron overload

1 reference

12 December 2020

Ocular toxicity of high-dose intravenous desferrioxamine

1 reference

12 December 2020